KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway
Open Access
- 16 July 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (33) , 53153-53164
Abstract
KRAS G12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathwayKeywords
This publication has 19 references indexed in Scilit:
- Paracrine Network: Another Step in the Complexity of Resistance to EGFR Blockade?Clinical Cancer Research, 2014
- MDM2–MOF–H4K16ac axis contributes to tumorigenesis induced by NotchThe FEBS Journal, 2014
- Oncogene Ras/Phosphatidylinositol 3-Kinase Signaling Targets Histone H3 Acetylation at Lysine 56Journal of Biological Chemistry, 2012
- Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular ClearanceDevelopmental Cell, 2011
- Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal CancerClinical Cancer Research, 2009
- WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activityNature, 2008
- Neuregulin3 alters cell fate in the epidermis and mammary glandBMC Developmental Biology, 2007
- Neuregulins 1–4 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breastBreast Cancer Research and Treatment, 2005
- Co‐expression of neuregulins 1, 2, 3 and 4 in human breast cancerThe Journal of Pathology, 2004
- The Ras/Raf/MEK/Extracellular Signal-Regulated Kinase Pathway Induces Autocrine-Paracrine Growth Inhibition via the Leukemia Inhibitory Factor/JAK/STAT PathwayMolecular and Cellular Biology, 2003